Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Amgen : Exploring Climate Change and Lung Health

09/27/2021 | 01:12pm EDT

When you turn on the news or scroll through your social media, it's become a regular occurrence to see the overwhelming effect that climate change is having on the world. Catastrophic events are everywhere, from rampant wildfires, historic heat waves and devastating floods - all directly related to climate change.

In partnership with Axios, Amgen recently hosted an Expert Voices roundtable on climate change and its impact on lung health. Leaders, subject matter experts and policy makers from across disciplines gathered virtually to discuss the widening socioeconomic disparities and how to better prepare for future and long-term effects of climate change on lung health.

Key takeaways from the discussion included:

  • Climate change is not a problem of tomorrow, it's a problem for today. These issues are becoming more recognized as the impacts start to directly affect larger portions of the population. However, current solutions are a temporary fix. Transitioning from a reactive to a predict and prevent approach can help to curtail the ripple effects of climate change.
  • Much like COVID-19, many climate change-related health issues first impact the most vulnerable communities. Solutions are needed to alleviate this disproportionate burden on these communities while also considering the existing challenges to resources and access they face.
  • Wildfire impact has swept across the country, from coast to coast. There's an increase in concentrations of particle matter in the air contributing to poor air quality, which has caused a significant uptick of ER visits for pulmonary issues.
  • All too often outdoor air quality is the only focus. COVID-19 has put a spotlight on indoor air quality as well. There have been more than 1,000 school closures in 38 states because of air quality issues, which is especially alarming for children's developing lungs.
  • While there are perceptions that transitioning to more sustainable power approaches are expensive, billions of dollars are spent on the cost of climate changebecause of the immense damage caused by non-renewable resources and the resulting hospital visits often for respiratory issues.

"It's clear now more than ever that climate change and health, particularly lung health, cannot wait. More than 90% of the global population breathes unhealthy air, a statistic that is only expected to increase on our current trajectory," said roundtable panelist Andrew Lindsley, M.D., Ph.D., medical director and U.S. Medical Affairs Asset Lead at Amgen. "While it was a sobering discussion, there is also hope - as seen through the efforts that my fellow roundtable participants are driving through their respective organizations. A key conclusion from the roundtable is that tackling climate change cannot be done by one group alone, but it will take many perspectives and disciplines to sound the alarm and develop solutions to bring change."

To read more about the conversation, visit Axios' event recap here.


Amgen Inc. published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 September 2021 17:11:06 UTC.

© Publicnow 2021
All news about AMGEN INC.
10/21AMGEN : Keeps Quarterly Dividend at $1.76 a Share, Payable Dec. 8 to Stockholders of Recor..
10/21AMGEN : Announces 2021 Fourth Quarter Dividend
10/21Amgen Inc. Declares Dividend for the Fourth Quarter of 2021, Payable on December 8, 202..
10/21AMGEN : Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multisp..
10/20AMGEN : A Special Edition of Innovation2, brought to you by David and Jim Reese (Brothers2..
10/20CARLYLE : Venture Funds Invest Up to $430 Million in Saama Technologies
10/19AMGEN : Completes Teneobio Acquisition
10/19AMGEN : Successfully Completes Acquisition Of Teneobio, Inc.
10/19AMGEN : Named One of the ‘World's Best Workplaces'
10/19Amgen Inc. completed the acquisition of TeneoBio, Inc. from Lightspeed Ventures, LLC an..
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2021 26 010 M - -
Net income 2021 5 801 M - -
Net Debt 2021 22 276 M - -
P/E ratio 2021 20,7x
Yield 2021 3,37%
Capitalization 119 B 119 B -
EV / Sales 2021 5,42x
EV / Sales 2022 5,08x
Nbr of Employees 24 300
Free-Float 99,8%
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 208,99 $
Average target price 243,14 $
Spread / Average Target 16,3%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.-9.10%118 675
JOHNSON & JOHNSON3.83%430 148
ROCHE HOLDING AG15.79%339 425
PFIZER, INC.16.27%240 303
NOVO NORDISK A/S56.55%239 079